|
Constance C. Bienfait, Vice President of Investor Relations and Corporate Communications - Constance C. Bienfait has served as Vice President of Investor Relations and Corporate Communications since March 2006. Ms. Bienfait brings over two decades of investor relations, public and media relations and corporate communications experience to Metabasis. Before joining Metabasis, she served as Vice President of Investor Relations at Nabi Biopharmaceuticals and prior to that served as Executive Director of Corporate Communications for Kos Pharmaceuticals. In both capacities, she managed all aspects of the companies’ investor, public and government relations, as well as internal communications. She also served as vice president at Morgen-Walke Associates, a New York City investor and public relations consulting firm, where she advised clients on all levels of strategic issues, crisis management, and disclosure requirements, as well as public relations, marketing and branding initiatives. Ms. Bienfait attended the London School of Economics graduate program and received her B.S. in Economics with honors from Trinity College in Hartford, Connecticut.
| 